Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel
Authors: Mahesh Tambe, Sofia Pruikkonen, Jenni Mäki-Jouppila, Ping Chen, Bente Vilming Elgaaen, Anne Hege Straume, Kaisa Huhtinen, Olli Cárpen, Per Eystein Lønning, Ben Davidson, Sampsa Hautaniemi, Marko J. Kallio
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.